Back to search
FDAFDA · Food and drugs·Recall number D-1086-2015

Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Therapeutics LLC, Miami, FL 33186, by Noven Pharmaceuticals Inc., Miami, FL 33186, NDC # 68968-5555-3

Published June 3, 2015 · Recall initiated: January 12, 2015

Summary

FDA records drug Class II recall D-1086-2015, published June 3, 2015 and initiated January 12, 2015. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 125,340 Patches; Lot: Lot # 73346, Exp 03/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: One lot exceeded the mechanical peel specification

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals, Inc.
Distributor
Nationwide
Lot
Lot # 73346, Exp 03/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Therapeutics LLC, Miami, FL 33186, by Noven Pharmaceuticals Inc., Miami, FL 33186, NDC # 68968-5555-3 recalled?

Yes. FDA published recall D-1086-2015 on June 3, 2015. Reported hazard: Defective Delivery System: One lot exceeded the mechanical peel specification

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.